ADM: Adalimumab; AUC 0-∞ ... SD + MTX Van De Putte et al. (2003) 12 weeks ADM 20 mg/week, sc. ADM 40 mg/week, sc. ADM 80 mg/week, sc. Weinblatt et al. (2003) (ARMADA) 24 weeks ADM 20 mg e2w ...

Discontinuing adalimumab increases relapse rates in patients with juvenile idiopathic arthritis (JIA)–associated uveitis. However, patients can regain inflammation control after resuming the ...

Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...